Abstract
In a previous article 1 we showed that the serum of a goat convalescing from a reaction produced by the inoculation of green-producing measles diplococci protected rabbits against a subsequent injection of infective material from measles. The rabbits injected with normal goat serum and those untreated showed some or all of the characteristics of measles in rabbits—a rise of temperature, Koplik spots and a rash. Convalescent goat serum protected human beings against measles as effectively as convalescent human measles serum when injected on the first and second days after exposure to measles. By intracutaneous tests in normal rabbits, the serum of goats injected with diplococci from measles as well as convalescent human measles serum was shown to neutralize the action of killed measles diplococci, while serum of normal goats had no such effect. Since convalescent goat serum appeared to protect against measles only if given on the first two days
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
